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The Organotelluride Catalyst (PHTE)2NQ Prevents
HOCl-Induced Systemic Sclerosis in Mouse
Wioleta K. Marut1,4, Niloufar Kavian1,4, Ame´lie Servettaz1,2, Carole Nicco1, Lalla A. Ba3, Mandy Doering3,
Christiane Che´reau1, Claus Jacob3, Bernard Weill1 and Fre´de´ric Batteux1
Systemic sclerosis (SSc) is a connective tissue disorder characterized by skin and visceral fibrosis, microvascular
damage, and autoimmunity. HOCl-induced mouse SSc is a murine model that mimics the main features of the
human disease, especially the activation and hyperproliferation rate of skin fibroblasts. We demonstrate here
the efficiency of a tellurium-based catalyst 2,3-bis(phenyltellanyl)naphthoquinone ((PHTE)2NQ) in the treatment
of murine SSc, through its selective cytotoxic effects on activated SSc skin fibroblasts. SSc mice treated with
(PHTE)2NQ displayed a significant decrease in lung and skin fibrosis and in alpha-smooth muscle actin (a-SMA)
expression in the skin compared with untreated mouse SSc animals. Serum concentrations of advanced
oxidation protein products, nitrate, and anti-DNA topoisomerase I autoantibodies were increased in SSc mice,
but were significantly reduced in SSc mice treated with (PHTE)2NQ. To assess the mechanism of action of
(PHTE)2NQ, the cytotoxic effect of (PHTE)2NQ was compared in normal fibroblasts and in mouse SSc skin
fibroblasts. ROS production is higher in mouse SSc fibroblasts than in normal fibroblasts, and was still
increased by (PHTE)2NQ to reach a lethal threshold and kill mouse SSc fibroblasts. Therefore, the effectiveness
of (PHTE)2NQ in the treatment of mouse SSc seems to be linked to the selective pro-oxidative and cytotoxic
effects of (PHTE)2NQ on hyperproliferative fibroblasts.
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INTRODUCTION
Systemic sclerosis (SSc) is an autoimmune disease of
unknown etiology, characterized by fibrosis of the skin and
internal organs, vascular dysfunction, and impaired immunity
(LeRoy and Medsger, 2001). However, the mechanisms that
underlie the clinical manifestations of the disease remain
unclear (Gabrielli et al., 2009). Several reports have shown
that reactive oxygen species (ROS) are involved in the
pathogenesis of SSc (Simonini et al., 1999; Sambo et al.,
2001; Allanore et al., 2004; Ogawa et al., 2006; Servettaz
et al., 2007; Avouac et al., 2010). Indeed, skin fibroblasts in
SSc patients spontaneously produce large amounts of ROS
that trigger collagen synthesis (Sambo et al., 1999, 2001).
Intradermal injection of specific ROS-generating substances
can reproduce the main features of local and systemic mouse
SSc, depending on the type of ROS generated (Servettaz et al.,
2009). In addition, anti-PDGFR (Platelet-Derived Growth
Factor Receptor) autoantibodies found in SSc patients
trigger the production of ROS (Svegliati Baroni et al., 2006).
Recently, we have reported that sera from patients with SSc
can induce the production of ROS not only by endothelial
cells but also by the proliferation of fibroblasts (Servettaz
et al., 2007). The release of ROS by fibroblasts and
endothelial cells can activate several processes that trigger
the development of SSc. In fact, ROS can oxidize specific SSc
antigens such as DNA topoisomerase 1 and lead to this
autoantigen’s breach of tolerance (Casciola-Rosen et al.,
1997; Servettaz et al., 2009). The autoimmune phenomenon
can be amplified by the inflammatory reaction that results
from the overproduction of ROS. This fibrotic process may
also be related to the imbalance of the oxidant/antioxidant
status in SSc. For instance, in vitro studies have shown that
ROS triggers the differentiation of fibroblasts into myofibro-
blasts, either directly or through the activation of the
ADAM17/NOTCH pathway (Kavian et al., 2010), and also
through the release of transforming growth factor-b from
activated cells (Bellocq et al., 1999). Finally, ROS can
stimulate the growth of dermal fibroblasts through the
activation of the RAS pathway, which explains the hyper-
proliferative properties of SSc skin fibroblasts (Svegliati et al.,
2005). However, if intracellular ROS can stimulate cell
growth, they can also induce cell death beyond a certain
threshold, as seen in tumor cells (Laurent et al., 2005; Morgan
& 2012 The Society for Investigative Dermatology www.jidonline.org 1125
ORIGINAL ARTICLE
Received 20 February 2011; revised 27 October 2011; accepted 29 October
2011; published online 26 January 2012
1Universite´ Paris Descartes, Sorbonne-Paris-Cite´, Faculte´ de Me´decine,
EA 1833 et Laboratoire d’Immunologie Biologique, Hoˆpital Cochin AP-HP,
Paris, France; 2Faculte´ de Me´decine de Reims, Service de Me´decine Interne,
Maladies Infectieuses, Immunologie Clinique, Hoˆpital Robert Debre´, Reims,
France and 3Division of Bioorganic Chemistry, School of Pharmacy, Saarland
University, Saarbru¨cken, Germany
Correspondence: Fre´de´ric Batteux, Laboratoire d’Immunologie, UPRES EA
1833, 8 Rue Me´chain 75679 Paris Cedex 14, France.
E-mail: frederic.batteux@cch.aphp.fr
4These authors contributed equally to this work.
Abbreviations: BSO, buthionine sulfoximine; GSH, glutathione; NO, nitric
oxide; (PHTE)2NQ, 2,3-bis(phenyltellanyl)naphthoquinone; ROS, reactive
oxygen species; SSc, systemic sclerosis
and Liu, 2010; Coriat et al., 2011; Lonkar and Dedon, 2011).
Interestingly, some catalytic agents called ‘‘sensor/effector’’
multifunctional redox catalysts can modulate the intracellular
redox balance by generating more reactive oxidants or by
targeting cysteine residues in proteins. These molecules seem
to be particularly effective and selective (Fry and Jacob,
2006). Among the ‘‘sensor/effector’’ multifunctional redox
catalyst agents, quinone- and chalcogen (selenium, tell-
urium)-containing agents have shown an in vitro cytotoxic
activity against various types of tumor cells (Doering et al.,
2010; Coriat et al., 2011; Lilienthal et al., 2011). These
observations have prompted us to try these new cytotoxic
organotelluride catalysts in the treatment of mouse SSc.
The organotelluride catalyst, 2,3-bis(phenyltellanyl)-
naphthoquinone ((PHTE)2NQ), is a prototypical member of
this newly described family (Fry and Jacob, 2006; Shabaan
et al., 2009; Ba et al., 2010; Jamier et al., 2010). Within this
family of compounds, (PHTE)2NQ has been the most widely
studied compound in vitro on tumor cells (Doering et al.,
2010; Jamier et al., 2010), and it has also been the only one
used in vivo on mice (Coriat et al., 2011). Intracellular
oxygen radicals and H2O2 associate with the quinone moiety
of the (PHTE)2NQ and strongly oxidize cellular thiols in a
reaction catalyzed by the tellurium part of the molecule. This
reaction significantly increases the intracellular level of ROS.
Therefore, cells already overproducing H2O2, which are
treated with (PHTE)2NQ, are likely to significantly increase
their intracellular concentration of ROS over its cytotoxic
level, to ultimately get pushed over a critical ‘‘life and death
(redox) threshold’’ (Fry and Jacob, 2006; Mecklenburg et al.,
2009). As mouse SSc fibroblasts produce high amounts of
H2O2, as opposed to normal fibroblasts, we hypothesize that
(PHTE)2NQ could selectively kill disease fibroblasts in
murine HOCl-induced SSc (Servettaz et al., 2009) and inhibit
the development of the disease.
RESULTS
(PHTE)2NQ exerted cytotoxic effects on normal and SSc
fibroblasts in vitro
Fibroblasts from normal mice and from HOCl mice were
exposed in vitro to increasing amounts of (PHTE)2NQ
(Supplementary data, Supplementary Figure 7 online) to
assess the cytotoxic properties of this ‘‘sensor/effector’’
multifunctional redox catalyst agent on those different types
of fibroblasts. In the presence of 1 mM (PHTE)2NQ, the rate of
viability of normal fibroblasts was 72% (P¼0.0001 vs.
untreated fibroblasts) and 68% with 4 mM (PHTE)2NQ
(P¼0.0001 vs. untreated fibroblasts; Figure 1a). (PHTE)2NQ
had a more powerful cytotoxic effect on diseased SSc
fibroblasts than on normal fibroblasts. In the presence of
1 mM (PHTE)2NQ, the rate of viability of SSc fibroblast was
45% (P¼0.0001 vs. untreated fibroblasts and vs. normal
fibroblasts) and 30% with 4 mM (PHTE)2NQ (P¼0.0001 vs.
untreated fibroblasts and vs. normal fibroblasts; Figure 1a).
(PHTE)2NQ exerted pro-oxidative effects in vitro
The basal production of H2O2 was increased by 56% in SSc
fibroblasts compared with normal fibroblasts (P¼0.001).
Production of nitric oxide (NO) was also higher in SSc
fibroblasts than in normal fibroblasts (P¼ 0.01). Incubation of
normal fibroblasts and SSc fibroblasts with increasing
amounts of (PHTE)2NQ dose-dependently increased the
production of H2O2 (P¼ 0.009 and P¼0.001, respectively)
and NO (P¼0.018 in both cases; Figure 1b and c).
Imbalance of glutathione (GSH) metabolism in fibroblasts
GSH is an essential cofactor of H2O2 catabolism. The basal
level of GSH was decreased by 22% in SSc fibroblasts
compared with normal fibroblasts (P¼0.0032). The level of
intracellular glutathione was higher (P¼0.0001) in normal
fibroblasts following exposure to 1mM (PHTE)2NQ than in
untreated normal fibroblasts. By contrast, the treatment of
diseased SSc fibroblasts with (PHTE)2NQ failed to increase
the level of intracellular glutathione (Figure 1d).
Modulations of H2O2 metabolism in SSc fibroblasts
We next investigated the mechanism of action of (PHTE)2NQ
using specific modulators of the enzymatic and nonenzy-
matic systems involved in H2O2 catabolism. Hydrogen
peroxide is converted into H2O by two sets of enzymes,
catalase and the GSH/GPx system. The latter uses reduced
glutathione as the cofactor. Depleting GSH with buthionine
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Figure 1. Effects of 2,3-bis(phenyltellanyl)naphthoquinone ((PHTE)2NQ) on
normal and diseased systemic sclerosis (SSc) fibroblasts in vitro. Primary
skin fibroblasts extracted from three different normal skins (normal fibroblasts)
or three different diseased skins (SSc fibroblasts) were tested. (a) Cytotoxic
effects of (PHTE)2NQ on normal and diseased SSc fibroblasts in vitro.
Cytotoxicity was assayed using the crystal violet method. Results are
expressed as the percentage of viable treated cells compared with untreated
cells. (b) Production of hydrogen peroxide by fibroblasts incubated with
increasing concentrations of (PHTE)2NQ. H2O2 levels were analyzed
spectrofluorometrically using 20,70-dichlorodihydrofluorescein diacetate
(H2DCFDA). (c) Production of nitric oxide (NO) by fibroblasts incubated with
increasing concentrations of (PHTE)2NQ. NO levels were analyzed
spectrofluorimetrically using diaminofluorescein-2 diacetate (DAF-2DA).
(d) Intracellular glutathione levels in fibroblasts treated with various
concentrations of (PHTE)2NQ. Glutathione (GSH) levels were analyzed
spectrofluorimetrically using monochlorobimane. *Po0.05, **Po0.01, and
***Po0.001. AU, arbitrary units; NS, not significant.
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sulfoximine (BSO) significantly increased H2O2 production in
SSc fibroblasts (P¼ 0.0007) and normal fibroblasts (P¼0.0029;
Figure 2a). Moreover, incubation with (PHTE)2NQ in
association with BSO increased H2O2 production by 10.9%
in normal fibroblasts and by 22% in SSc fibroblasts compared
with BSO alone (P¼ 0.001, data not shown). By contrast,
adding N-acetylcysteine, a precursor of GSH, decreased
H2O2 production in normal fibroblasts (P¼0.04) but had no
effect on SSc fibroblasts (Figure 2a). On the other hand,
specific inhibition of catalase by aminotriazol, or addition of
exogenous catalase, had no effect on the levels of H2O2 in
normal and SSc fibroblasts (Figure 2a). Depleting GSH with
BSO significantly decreased the viability of SSc fibroblasts
(P¼0.0026) and normal fibroblasts (P¼0.017). By contrast,
specific inhibition of catalase by aminotriazol had no effect
on the viability of normal and SSc fibroblasts (Figure 2b).
Moreover, suboptimal doses of BSO and (PHTE)2NQ worked
jointly to kill SSc fibroblasts more efficiently than (PHTE)2NQ
alone (P¼ 0.0168) (Figure 2c).
Determination of cell death pathway in normal and SSc
fibroblasts
Fibroblasts from normal and HOCl mice were incubated with
1, 2, and 4 mM of (PHTE)2NQ for 12, 24, 36, or 48 hours. The
highest cytotoxic effect of (PHTE)2NQ was observed at a
concentration of 4 mM. At this concentration, the viability was
decreased by 73% for SSc fibroblasts and only by 14.2% for
normal fibroblasts (P¼ 0.001). A kinetic analysis of cell death
between 12 and 48 hours indicated that the (PHTE)2NQ
effects are mainly mediated through a necrotic process
(Figure 3).
(PHTE)2NQ decreased both skin and lung fibrosis in mice
with SSc
Clinically, HOCl-induced SSc in mice (HOCl-mice) is
associated with an increase in dermal thickness that is
significantly reduced by (PHTE)2NQ (P¼ 0.0001 vs. un-
treated SSc mice; Figure 4a). Histopathological analysis of
skin (Figure 4c) and lung (Figure 5a) biopsies stained with
hematoxylin and eosin, and lung biopsy stained with
Sirius Red (Figure 5c), confirmed the dermal thickness
reduction and evidenced a decrease in fibrosis in both tissues
(Figures 4c, and 5a, c). (PHTE)2NQ reduced the accumulation
of type I collagen induced by HOCl in the skin compared
with untreated mice (Figure 4b). We also investigated the
effects of (PHTE)2NQ in the bleomycin model and found the
data to yield results similar to those obtained by the HOCl
model in terms of skin fibrosis. However, no lung fibrosis was
200
***
Normal fibroblasts
SSc fibroblasts
**
180
160
140
120
100
Pr
od
uc
tio
n 
of
H
2O
2 
(%
)
80 *
60
140
120 *
*
**
Vi
ab
ilit
y 
(%
)
Vi
ab
ilit
y 
(%
)
100
80
60
100
80
*
*
60
NA
C
BS
O AT
Z Ca
t
NA
C
BS
O AT
Z Ca
t
(PH
TE) 2
NQ
 0.5
 μM
(PH
TE) 2
NQ
 + 
BS
O
BS
O 0
.8 
mM
Figure 2. Modulation of H2O2 metabolism by 2,3-bis(phenyltellanyl)naphthoquinone ((PHTE)2NQ) in systemic sclerosis (SSc) fibroblasts. (a) Percentage of
H2O2 production by treated fibroblasts compared with untreated fibroblasts in the presence of specific modulators of the enzymatic systems involved in reactive
oxygen species (ROS) metabolism. The concentrations used were as follows: 3.2mM N-acetylcysteine (NAC), 0.8mM buthionine sulfoximine (BSO), 400 mM
aminotriazol (ATZ), and 20U catalase (Cat). (b) Viability of normal and SSc fibroblasts in the presence of 3.2mM NAC, 0.8mM BSO, 400 mM ATZ, and 20U
catalase. (c) Cytotoxic effects of (PHTE)2NQ on normal and diseased SSc fibroblasts in vitro. Cytotoxicity was assayed using the crystal violet method. Results
are expressed as percentage of viable treated cells compared with untreated cells. *Po0.05, **Po0.01, and ***Po0.001.
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Figure 3. Analysis of cell death by fluorescence-activated cell sorting. Apoptosis/necrosis was analyzed by flow cytometry using the Membrane Permeability/
Dead Cell Apoptosis Kit with YO-PRO-1 and propidium iodide (PI) on isolated normal and systemic sclerosis (SSc) fibroblasts treated with 4 mM of 2,3-
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observed after 5 weeks of bleomycin injections (Supplemen-
tary data, Supplementary Figure 8 online).
Furthermore, alpha-smooth muscle actin (a-SMA)
staining in skin sections showed that HOCl-treated SSc
animals displayed increased numbers of myofibroblasts
(9.53%±0.483 of positive area) compared with phosphate-
buffered saline (PBS)–injected mice (2.46%±0.555 of
positive area, P¼ 0.0001); Figure 4e and f). The number
of myofibroblasts was reduced by 47.6% after treating
HOCl-mice with (PHTE)2NQ (P¼ 0.0005). (PHTE)2NQ
also reduced the concentration of type I collagen in the
lungs of HOCl-mice by 26.7% (P¼0.0106; Figure 5a
and b).
Decrease of dermal thickness in SSc mice through (PHTE)2NQ
curative treatment
(PHTE)2NQ decreased dermal thickness when administered
as a curative treatment. Mice with SSc were treated with
(PHTE)2NQ (10mg kg
1 of (PHTE)2NQ), which was adminis-
tered intravenously once a week for 2 weeks. After 2 weeks,
the dermal thickness in treated mice was significantly less
than that in the untreated group (P¼ 0.0151; Figure 4d).
(PHTE)2NQ reduced the concentration of serum AOPP and
nitrite production
Advanced oxidation protein products (AOPP), a marker of
systemic oxidative stress, increased in the sera of HOCl-mice
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Figure 4. Effect of 2,3-bis(phenyltellanyl)naphthoquinone ((PHTE)2NQ) on skin fibrosis induced by HOCl in BALB/c mice. Subcutaneous injections of
HOCl or phosphate-buffered saline (PBS) were administered every day for 6 weeks in the back of mice, and intraveneous injections of (PHTE)2NQ (10mgkg
1)
were administered once a week for 6 weeks (n¼ 7–10 mice per group as described in the materials and methods section). (a) Dermal thickness, as measured
on skin sections in the injected areas of BALB/c mice. (b) Collagen content in 4-mm punch biopsy of skin as assayed by the Sircol method. (c) Representative
skin sections comparing dermal fibrosis in the injected areas from BALB/c mice. 1, PBS; 2, (PHTE)2NQ; 3, HOCl; 4, HOClþ (PHTE)2NQ. Tissue sections
were stained with hematoxylin and eosin. Bar¼ 100mm (Olympus DP70 Controller). (d) Curative treatment of SSc mice with (PHTE)2NQ. (e) Percentage of
positive areas for alpha-smooth muscle actin (a-SMA). (f) a-SMA expression in mouse skin by immunohistochemistry. *Po0.05 and ***Po0.001.
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Figure 5. Effect of 2,3-bis(phenyltellanyl)naphthoquinone ((PHTE)2NQ) on lung fibrosis induced by HOCl in BALB/c mice. Subcutaneous injections
of HOCl or phosphate-buffered saline (PBS) were administered every day for 6 weeks in the back of mice, and intraveneous injections of (PHTE)2NQ
(10mg kg1) were administered once a week for 6 weeks (n¼7–10 mice per group as described in the materials and methods section). (a) Representative lung
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compared with PBS control mice (P¼0.0001; Figure 6a).
Treatment of HOCl-mice with (PHTE)2NQ reduced the levels
of AOPP by 40%, compared with untreated SSc animals
(P¼0.0001; Figure 6a). The level of nitrite in the sera, a
marker of systemic nitrosative stress, increased in HOCl-mice
compared with PBS control mice (P¼0.0006; Figure 6b).
Treatment with (PHTE)2NQ in HOCl mice reduced the levels
of serum nitrite by 18% compared with untreated SSc mice
(P¼0.039; Figure 6b).
(PHTE)2NQ reduced serum concentration of anti-DNA
topoisomerase 1 Abs
The sera of HOCl mice contained significantly higher amounts
of DNA topoisomerase I Abs than the sera of mice treated with
PBS (P¼0.0008). The level of anti-DNA topoisomerase I Abs
significantly reduced in HOCl mice treated with (PHTE)2NQ
compared with untreated HOCl mice (P¼ 0.04; Figure 6c).
DISCUSSION
In this report, inspired by recent results obtained—by us and
others—in cancer therapy using selective pro-oxidative
molecules, we demonstrated that organotelluride catalysts
can combine with endogenous oxidative species generated
‘‘naturally’’ in mouse SSc fibroblasts to selectively kill cells
through a necrotic process.
Primary fibroblasts extracted from diseased skin areas
display an elevated basal level of ROS, which is amplified by
(PHTE)2NQ to generate a lethal oxidative burst in contrast
with healthy fibroblasts that display a normal level of
endogenous ROS and resist the action of (PHTE)2NQ.
The cytotoxic effects of ROS result from an imbalance
between their rate of production and the activity of various
detoxification systems (Laurent et al., 2005). Indeed, in SSc
fibroblasts, the level of GSH is low and is not modified by
(PHTE)2NQ, whereas in normal fibroblasts this level is higher
and is raised by (PHTE)2NQ. Thus, when normal fibroblasts
are exposed to (PHTE)2NQ, the pro-oxidative activity of the
compound is counterbalanced by the rise of GSH and no
oxidative stress can be induced. In contrast, in diseased
fibroblasts, (PHTE)2NQ induces a huge increase in ROS that
is not counterbalanced by the low level of induced GSH, and
thus reaches a lethal threshold. Because the level of
endogenous ROS in SSc fibroblasts is close to that threshold,
exposure to ROS-generating, redox-modulating agents, such
as (PHTE)2NQ, enhances the rate of cell death. As normal
fibroblasts are not targeted by (PHTE)2NQ, this information
could have important clinical implications (Amstad et al.,
1991; Rodriguez et al., 2000; Hussain et al., 2004; Laurent
et al., 2005).
The depletion of GSH by BSO, and the consecutive
increase of (PHTE)2NQ toxicity in SSc and normal fibroblasts,
confirms the role of the GSH pathway in mediating the
cytotoxic effects of (PHTE)2NQ. In contrast, blocking the
catalase pathway or adding polyethylene glycol catalase
showed that this pathway has no effect on cell survival,
regardless of the considered cell type. Thus, H2O2-mediated
(PHTE)2NQ toxicity is controlled by the glutathione pathway
and not by the catalase pathway, as already observed with
several cytotoxic molecules (Jing et al., 1999; Hussain et al.,
2004; Laurent et al., 2005; Alexandre et al., 2006). These
findings are significant, as they seem to identify disturbances
in the GSH household (and subsequent increases in ROS
levels), rather than ROS generation per se, as the prime
activity of such redox modulating agents.
In SSc, local oxidative stress is associated with a systemic
oxidative state, as demonstrated by the significant increase in
the serum concentrations of advanced oxidation protein
products, and of nitrite, in HOCl-treated SSc mice that are
compared with PBS-injected animals. Therefore, (PHTE)2NQ
induces a lethal oxidative burst in cells with increased levels
of intracellular ROS, but it is not a systemic pro-oxidative
molecule, as already observed in various cancer models (Fry
and Jacob, 2006; Doering et al., 2010; Coriat et al., 2011).
Several reports have linked the intracellular oxidative burst
and the initiation of the immune response in human or murine
models of SSc (Simonini et al., 1999; Harjardo et al., 2010).
Indeed, local generation of HOCl or hydroxyl radicals
triggers the production of anti-DNA–topoisomerase 1 auto-
antibodies; consequently, the generation of peroxynitrite
triggers the production of anti-centromeric protein B Abs.
The mechanism through which the breach of tolerance to
DNA topoisomerase 1 occurs, following exposure to HOCl or
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nitrite concentration, and anti-DNA topoisomerase 1 antibodies (Abs) in mice sera. HOCl or PBS was injected subcutaneously every day for 6 weeks in
the back of mice. (PHTE)2NQ (10mg kg
1) was similarly injected once a week for 6 weeks (n¼ 7–10 mice per group as described in the Materials and
Methods section). Sera were collected at the time of sacrifice. (a) Serum concentration of AOPP in the sera of mice. (b) Serum concentration of nitrite in the
sera of mice. (c) Levels of serum anti-DNA topoisomerase 1 Abs. Values are means±SEM of data gained from all mice in the experimental or control
groups. *Po0.05 and ***Po0.001. AU, arbitrary units; PBS, phosphate-buffered saline.
www.jidonline.org 1129
WK Marut et al.
Organotelluride Catalyst (PHTE)2NQ
hydroxyl radicals, is related to the oxidation and cleavage of
DNA topoisomerase 1 within the cells (Servettaz et al., 2009).
The selective destruction of diseased fibroblasts that chroni-
cally produce high levels of intracellular ROS by (PHTE)2NQ
probably explains the decreased concentration of circulating
oxidized proteins in the sera, and especially of oxidized
DNA topoisomerase 1 anti-DNA–topoisomerase 1 Abs.
Furthermore, oxidized topoisomerase 1 exerts a proprolifera-
tive effect on fibroblasts and increases the intracellular level
of H2O2 in fibroblasts and endothelial cells. The decrease of
circulating oxidized proteins linked to the selective destruc-
tion of diseased fibroblasts also explains the decrease in
fibroblast proliferation.
One of the major consequences of oxidative stress in
diseased fibroblasts is their transformation into myofibroblasts
and their increased production of type I collagen (Sambo
et al., 2001; Toullec et al., 2010). As for autoantibodies and
fibroblast proliferation, the selective destruction of diseased
mouse SSc fibroblasts by (PHTE)2NQ is followed by a
decrease in the number of myofibroblasts. These phenomena
were associated with the inhibition of the development of
mouse SSc because they were correlated with a decrease in the
concentration of type I collagen in the skin of treated animals.
Altogether, our results show that the organotelluride
catalyst (PHTE)2NQ can interact with intracellular ROS
generated in SSc fibroblasts to selectively kill the cells. This
observation suggests a new therapeutic strategy in SSc, based
on the modulation of the intracellular redox state of activated
fibroblasts. Indeed, new molecules, such as (PHTE)2NQ,
could help selectively eliminate the activated cells respon-
sible for the development of skin and visceral fibrosis and,
indirectly, be used for autoimmunity. Preliminary data
suggest that the molecule is not only efficient as a preventive
treatment, but also as a curative treatment of SSc.
MATERIALS AND METHODS
Animals and chemicals
Specific pathogen-free, 6-week-old female BALB/c mice were used
in all experiments (Harlan, Gannat, France). All mice were housed in
autoclaved ventilated cages with sterile food and water ad libitum.
They were given humane care according to the guidelines of
our institution. HOCl was administered as previously described
(Servettaz et al., 2009). Briefly, 300ml of HOCl was injected sub-
cutaneously into the back of the mice 5 days per week for 6 weeks.
One week after the end of the injections, the animals were killed by
cervical dislocation. Serum and tissue samples were collected from
each mouse and stored at 801C until use or fixed in 10% acetic
acid formol for histopathological analysis. For (PHTE)2NQ admin-
istration, BALB/c mice treated with HOCl (n¼ 10) or not treated
(n¼ 7) were injected intravenously with (PHTE)2NQ (10mg kg1 per
injection diluted in PBS once per week for 6 weeks). As the control
group, BALB/c mice treated with HOCl (n¼ 10) and those that were
not (n¼ 7) were injected intravenously with sterilized PBS once per
week for 6 weeks.
All cells were cultured as reported previously (Servettaz et al.,
2009). All chemicals were from Sigma-Aldrich (Saint Quentin Fallavier,
France), except when specified. The detailed synthesis of (PHTE)2NQ
appears in Supplementary data online.
Isolation of fibroblasts from the skin of mice
HOCl or PBS was injected in the same skin area in all mice. Skin
samples were then collected from that area for experimental
purposes. The samples were digested with ‘‘Liver Digest Medium’’
(Invitrogen Life Technologies, Grand Island, NY) for 1 hour at 371C.
After three washes in complete medium, cells were seeded into
sterile flasks, and isolated fibroblasts were cultured in DMEM/
Glutamax-I supplemented with 10% heat-inactivated fetal calf
serum and antibiotics, at 371C in a humidified atmosphere contain-
ing 5% CO2.
Viability assays
Isolated normal and SSc fibroblasts (4 103 cells per well; Costar,
Corning, NY) were incubated in 96-well plates with complete
medium alone, or with 1, 2, or 4mM of (PHTE)2NQ for 48 hours at
371C. The number of viable cells was evaluated by the crystal violet
assay. In brief, cells were stained in 0.5% crystal violet and 30%
ethanol in PBS for 30minutes at room temperature. After two washes
in PBS, the stain was dissolved in 50% ethanol and absorbance was
measured at 560 nm on a microplate reader (Fusion, PerkinElmer,
Wellesley, MA). Results are expressed as percentage of viable treated
cells compared with untreated cells.
H2O2 and NO production, and levels of intracellular reduced
glutathione
Isolated normal and SSc fibroblasts (2 104 cells per well) were
seeded in 96-well plates (Costar) and incubated for 24 hours at 371C
with either medium alone or with 0.5, 1, or 2 mM of (PHTE)2NQ.
Levels of H2O2 and NO were assessed spectrofluorometrically
(Fusion, PerkinElmer) using 20,70-dichlorodihydrofluorescein diace-
tate and diaminofluorescein-2 diacetate, respectively.
Cells were incubated with 200mM of 20,70-dichlorodihydrofluor-
escein diacetate or 200mM diaminofluorescein-2 diacetate in
PBS for 1 hour at 371C. The excitation and emission wavelengths
used were 490 and 535nm for 20,70-dichlorodihydrofluorescein
diacetate and 485 and 530nm for diaminofluorescein-2 diacetate,
respectively.
The levels of intracellular glutathione were assessed spectro-
fluorometrically using monochlorobimane staining. Cells were then
washed and incubated with 50 mM monochlorobimane for 15min-
utes at 371C. The fluorescence intensity was measured with
excitation and emission wavelengths of 380 and 485nm, respec-
tively. The intracellular H2O2 and NO levels, and the intracellular
glutathione level, were expressed as arbitrary units of fluorescence
intensity normalized by the number of viable cells. The number of
viable cells at the end of the experiments was evaluated by the
crystal violet assay as described above.
Analysis of ROS metabolism of normal and SSc fibroblasts
Isolated normal or SSc fibroblasts (2 104 cells per well) were
seeded in 96-well plates and incubated for 24 hours in complete
medium alone or with the following molecules: 3.2mM N-
acetylcysteine, 1.6mM BSO, 400 mM aminotriazol, or 20U poly-
ethylene glycol catalase. Cells were then washed three times with
PBS and incubated with 100ml per well of 200mM 20,70-dichloro-
dihydrofluorescein diacetate for 30minutes. Fluorescence intensity
was read as described above. Intracellular H2O2 levels were also
expressed as described above.
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Synergistic effect of BSO and (PHTE)2NQ on normal and SSc
fibroblasts
Isolated normal or SSc fibroblasts (2 104 cells per well) were
seeded in 96-well plates and incubated for 24 hours in complete
medium alone or with the following molecules: 0.8mM BSO and
0.5 mM (PHTE)2NQ, alone or in association. The number of viable
cells at the end of the experiments was evaluated by the crystal violet
assay as described above.
Analysis of cell death by fluorescence-activated cell sorting
Cell death was analyzed by fluorescence-activated cell sorting
(FACS)Canto II flow cytometer (Becton Dickinson, Franklin Lakes,
NJ), using the Membrane Permeability/Dead Cell Apoptosis Kit
with YO-PRO-1 and propidium iodide for flow cytometry
(Invitrogen), under the manufacturer’s recommendations. Briefly,
1.2 104 normal or SSc fibroblasts isolated from the skin were
incubated with 1, 2, or 4 mM (PHTE)2NQ for 12, 24, 36, or
48 hours. After the incubation period, the cells were collected,
washed twice with PBS, stained on ice for 10minutes with 1.5 mM
propidium iodide and 0.1 mM YO-PRO-1, and analyzed by flow
cytometry.
Dermal thickness
Skin thickness was measured 1 day before killing using a calliper and
was expressed in millimeters (Servettaz et al., 2010).
Collagen content in skin and lung
Skin was taken from the back region of mice with a punch (6mm of
diameter), and lung pieces from each mouse were diced using a
sharp scalpel and then put into aseptic tubes, thawed, and mixed
with pepsin (1:10 weight ratio) and 0.5 M acetic acid. Collagen
content was assayed using the quantitative dye-binding Sircol
method (Biocolor, Belfast, N. Ireland; Burdick et al., 2005). The
concentration values were read at 540 nm on a microplate reader
(Fusion, PerkinElmer) versus a standard range of bovine collagen
type I concentrations (supplied as a sterile solution in 0.5 M acetic
acid).
Curative treatment
BALB/c mice were injected subcutaneously with 300 ml HOCl
5 days per week for 5 weeks to induce mouse SSc. SSc mice were
then distributed randomly into two groups. The experimental group
of treated mice (n¼ 5) received 10mg kg1 of (PHTE)2NQ adminis-
tered intravenously once a week for 2 weeks. The control group
(n¼ 5) received intravenous saline. Dermal thickness in SSc mice
was measured after 2 weeks of treatment with (PHTE)2NQ.
Histopathological analysis
Fixed lung and skin pieces were embedded in paraffin. A 5-mm-thick
tissue section was prepared from the mid-portion of the paraffin-
embedded tissue and stained with either hematoxylin eosin or Sirius
red. Slides were examined by a pathologist blinded to the animal
group assignment, via standard bright-field microscopy (Olympus
BX60, Tokyo, Japan).
Analysis of a-SMA expression in mouse skin
Expression of a-SMA in mouse skin was analyzed by immunohis-
tochemistry. Tissue sections were dewaxed and then incubated with
200mgml1 proteinase K for 15minutes at 371C for antigen
retrieval. Specimens were then treated with 3% hydrogen peroxide
for 20minutes at 371C to inhibit endogenous peroxidases, and then
blocked with 5% BSA for 30minutes at 41C. Sections were
incubated with a 1:100 dilution of a monoclonal anti-a-SMA,
alkaline phosphatase-conjugated Ab (Sigma-Aldrich). Antibody
binding was visualized using Nitro blue tetrazolium chloride/
5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP). The slides were
examined by standard bright-field microscopy (Olympus BX60).
Appropriate controls with irrelevant alkaline phosphatase-conju-
gated Ab were performed.
Determination of AOPP concentrations in sera
AOPP was measured by spectrophotometry as previously described
(Servettaz et al., 2009). Calibration used chloramine-T within the
range of 0–100mmol l1. AOPP concentrations were expressed as
mmol l1 of chloramine-T equivalents.
Quantification of nitrite in mouse sera
The concentration of nitrite was determined in sera by a spectro-
photometric assay using oxidation catalyzed by cadmium metal
(Oxis, Portland, OR), which converts nitrate into nitrite. The total
determined nitrite corresponds to NO production. The detection
threshold for nitrite was 0.1 mmol l1 (Sastry et al., 2002).
Detection of serum autoantibody
Serum anti-DNA topoisomerase 1 IgG Abs were assayed by ELISA
using purified calf thymus DNA topoisomerase 1 bound to the wells
of a microtiter plate (Immunovision, Miami, FL). Plates were blocked
with PBS-1% BSA, and 100 ml of 1:20 mouse serum was added and
allowed to react for 1 hour at room temperature. Bound Abs
was detected with alkaline phosphatase–conjugated goat anti-
mouse IgG Ab, and the reaction was developed by adding
p-nitrophenyl phosphate. Optical density was measured at 405 nm
using a Dynatech MR 5000 microplate reader (Dynex Technology,
Chantilly, VA).
Statistical analysis
All quantitative data were expressed as means±SEM. Data were
compared using the Mann–Whitney nonparametric test or Student’s
t-paired test.
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